Report No. 9/2026 Conclusion of an advisory agreement regarding regulatory support in the U.S. market

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Company”, the “Issuer”) hereby announces that on April 13, 2026, it concluded an advisory agreement with a specialized advisory entity regarding support for the development process of the Company’s stem cell-based veterinary medicinal products in the U.S. market. The agreement […]